# KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers

> **NCT04473690** · PHASE1,PHASE2 · COMPLETED · sponsor: **KBio Inc** · enrollment: 102 (actual)

## Conditions studied

- Covid19

## Interventions

- **BIOLOGICAL:** Low Dose of KBP-COVID-19
- **BIOLOGICAL:** High Dose of KBP-COVID-19
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04473690
- **Lead sponsor:** KBio Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-30
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-10-14
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04473690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04473690, "KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04473690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*